In 2020, an expert consensus developed an initial framework for remission in asthma that includes a sustained absence of ...

But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.

GSK (GSK) announced that the China National Medical Products Administration has approved Nucala, a monoclonal antibody that ...

GSK (NYSE:GSK) has received Chinese regulatory approval for its drug Nucala, also known as mepolizumab, for the treatment of ...

It has been recommended for approval by the EMA’s human medicines committee – the CHMP – as a once-daily maintenance treatment for patients whose asthma can’t be controlled with two-drug ...

The study offers promising solutions ... First New Treatment for Asthma Attacks in 50 Years Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more ...

On Friday, the China National Medical Products Administration approved GSK plc (NYSE:GSK) Nucala (mepolizumab) as an add-on ...

Following 2 weeks of prednisolone 30 mg, patients demonstrating an improvement in asthma control were randomised to receive either ciclesonide 320 µg twice daily or placebo in addition to usual ...

Continuous positive airway pressure (CPAP)—which uses a machine that pushes pressure into your airways to prevent their inward collapse—is the primary treatment for obstructive sleep apnea (OSA).

this could signify that you need better maintenance of your asthma. Treatment of severe asthma can improve VC. Restrictive lung diseases make it hard for you to inhale. Conditions like pneumonia, ...

You may have recently heard about SMART (Single Maintenance and Reliever Therapy). It’s a somewhat new approach to asthma management that combines the use of a single inhaler for both ...